about
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting ...
Read More
1.17
0.01
(0.86%)
1.7M
XNAS Volume
XNAS 06 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Immunic Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..